Related Experiment Video
Updated: Mar 12, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Paradoxical reactions in children with tuberculosis
1Paediatric TB Clinic, BJ Wadia Hospital for Children, Mumbai, India.
The paradoxical reaction (PR) to tuberculosis treatment occurred in 3.3% of children, manifesting as enlarged lymph nodes, CNS tuberculomas, and serositis. This reaction predominantly affected boys and appeared around 3.5 months after starting anti-TB medication.
Area of Science:
- Pediatrics
- Infectious Diseases
- Immunology
Background:
- Tuberculosis (TB) treatment can trigger immune reconstitution inflammatory syndrome (IRIS).
- The paradoxical reaction (PR), a form of IRIS, involves worsening of TB symptoms despite effective anti-TB therapy.
- Understanding PR in children is crucial for optimizing TB management.
Purpose of the Study:
- To determine the incidence and clinical spectrum of paradoxical reactions (PR) in children undergoing tuberculosis (TB) treatment.
- To identify demographic and clinical factors associated with PR in pediatric TB patients.
Main Methods:
- A cohort of 1000 children with TB was retrospectively analyzed.
- Incidence, clinical presentations, and demographic data of PR were documented.
- Age-specific patterns of PR manifestations were investigated.
Main Results:
- The incidence of PR was 3.3% among 1000 children treated for TB.
- Common PR manifestations included mediastinal adenopathy, CNS tuberculoma, lymph node enlargement, and serositis.
- PR onset averaged 3.5 months post-anti-TB initiation, predominantly in boys, with age-related variations in presentation.
Conclusions:
- Paradoxical reactions represent a significant complication in pediatric TB treatment, requiring vigilant monitoring.
- Clinical presentation of PR varies by age, with mediastinal adenopathy in younger children and tuberculomas in older children.
- Further research into the immunopathogenesis of PR in children is warranted.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pharmacokinetics in Pediatric Patients: Drug Metabolism